158 related articles for article (PubMed ID: 2854337)
1. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain).
Ubertini TR; Cioni C; Perini L; Gagnoni S
Vaccine; 1988 Dec; 6(6):481-2. PubMed ID: 2854337
[TBL] [Abstract][Full Text] [Related]
2. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
4. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
6. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
[TBL] [Abstract][Full Text] [Related]
7. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
8. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
9. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
11. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
Almond JW; Westrop GD; Evans DM; Dunn G; Minor PD; Magrath D; Schild GC
J Virol Methods; 1987 Aug; 17(1-2):183-9. PubMed ID: 2822753
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
14. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
15. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
Buttinelli G; Donati V; Fiore S; Marturano J; Plebani A; Balestri P; Soresina AR; Vivarelli R; Delpeyroux F; Martin J; Fiore L
J Gen Virol; 2003 May; 84(Pt 5):1215-1221. PubMed ID: 12692287
[TBL] [Abstract][Full Text] [Related]
17. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.
Equestre M; Genovese D; Cavalieri F; Fiore L; Santoro R; Perez Bercoff R
J Virol; 1991 May; 65(5):2707-10. PubMed ID: 1850043
[TBL] [Abstract][Full Text] [Related]
18. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
Martín J; Minor PD
J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
Rezapkin GV; Douthitt M; Dragunsky E; Chumakov KM
Virus Res; 1999 Dec; 65(2):111-9. PubMed ID: 10581384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]